DECIDE: Developing Tools for Lung Cancer Screening Discussion Improvement

Summary

The purpose of this study is to learn about discussion between clinicians and their patients related to lung screening. Survey answers will be collected from both clinicians and their patients.

Conditions

• Smoking
• Smoking, Tobacco
• Smoking, Cigarette
• Lung Cancer

Interventions

BEHAVIORAL

Cataldo Lung Cancer Stigma Scale (Smoking-Related Subscale)

Perceived Smoking-Related Stigma will be measured using the 5-item Cataldo Lung Cancer Stigma Scale (Smoking-Related Subscale). The response scale is 1 = strongly disagree, to 4 = strongly agree, and scores range from 5 to 25 (high stigma). Cronbach's alphas were 0.75 to 0.89 in prior studies.

BEHAVIORAL

Patient Trust in the Medical

Medical Mistrust will be measured using the 5-item Patient Trust in the Medical Profession Scale.80 The five-point Likert responses measure the extent to which patients perceive their clinician to be honest, caring more about convenience, thorough and careful, and trusted. The range of scores is 5 to 25 (higher mistrust). Reliability and validity have been well established with a Cronbach"s alpha of 0.84.

BEHAVIORAL

Decision Conflict Scale (DCS) - Lung Cancer Screening

The DCS is a 16-item Likert-response item scale that has been modified for the lung cancer screening and smoking cessation contexts. The DCS was developed by O"Connor,74-75 and validated in many health decisions including breast cancer screening with Cronbach"s alphas ranging from 0.78 to 0.81. 74-75 Despite its name, the DCS measures more than decision conflict to encompass personal perceptions of perceived decision-making quality such as feeling the choice is informed, values based, and likely to be implemented as well as expressing satisfaction with the decision. 74-75 The DCS is comprised of items with response options ranging from 1 (strongly disagree) to 5 (strongly agree). The items are summed to total scale score with lower scores reflective of higher decision conflict and higher scores reflective of lower decision conflict.

BEHAVIORAL

Shared Decision Making Questionnaire (SDM-Q)- Patient

Shared Decision Making Process will be measured from the patient perspective using the 9-item Shared Decision Making Questionnaire (SDM-Q-9),77 which has been validated with a Cronbach"s alpha of 0.94.

BEHAVIORAL

Stage of Readiness for Smoking Cessation - Contemplation Ladder

Among current smokers

BEHAVIORAL

Primary Care Clinicians' Lung Cancer Screening Survey

Includes items to assess attitudes, barriers, and knowledge of lung cancer screening guidelines.

Sponsors & Collaborators

• National Cancer Institute (NCI)

  collaborator NIH

• Indiana University

  collaborator OTHER

• University of North Carolina

  collaborator OTHER

• Memorial Sloan Kettering Cancer Center

  collaborator OTHER

• Kaiser Permanente

  collaborator OTHER

• Hackensack Meridian Health

  lead OTHER

Principal Investigators

• Jamie Ostroff, PhD · Memorial Sloan Kettering Cancer Center

• Lisa Carter-Bawa, PhD · Hackensack Meridian Health

Eligibility

Min Age

18 Years

Max Age

80 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2019-03-22

Primary Completion

2023-01-10

Completion

2023-01-10

Countries

• United States

Study Locations